Postoperative bowel dysfunction in patients with rectal cancer - Does a minimally invasive surgical approach improve outcomes?

Laparoscopy Low anterior resection syndrome Minimally invasive surgery Postoperative bowel dysfunction Rectal cancer Robotic surgery

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
03 Sep 2024
Historique:
received: 11 05 2024
revised: 13 08 2024
accepted: 02 09 2024
medline: 8 9 2024
pubmed: 8 9 2024
entrez: 7 9 2024
Statut: aheadofprint

Résumé

The purpose of this study was to evaluate the association of MIS approaches for rectal cancer with long-term postoperative bowel dysfunction. This was an Institutional Review Board-approved observational cohort study including consecutive patients with rectal or rectosigmoid cancer who underwent surgical resection between 2007 and 2017. The primary exposure was surgical approach, defined as open surgery or MIS (laparoscopy or robotic surgery). The primary outcome was major LARS, defined as a LARS score of ≥30. Subgroup analyses were performed by tumor height and type of MIS approach. Among 749 potentially eligible patients, 514 (68.6 %) responded to the survey and were included for analysis. In total, 195 (37.9 %) patients underwent an MIS approach - 117 (60.0 %) laparoscopic and 78 (40.0 %) robotic. At a median follow-up of 6.1 (3.7-9.6) years from surgery, 222 patients (43.2 %) had major LARS (MIS: 41.0 % vs. open: 44.5 %, p = 0.44). On multivariable logistic regression, surgical approach had no association with major LARS (MIS, aOR: 1.21, 0.79-1.86). Older age (aOR: 1.03, 1.01-1.04), female sex (aOR: 1.75, 1.16-2.67), TME (aOR: 1.74, 1.01-3.02), diverting ileostomy (aOR: 2.74, 1.49-5.02) and radiation therapy (aOR: 2.63, 1.60-4.33) were all associated with major LARS. On subgroup analysis of patients with mid and low rectal cancers (n = 197), there remained no association between surgical approach and major LARS (MIS, aOR: 1.50, 0.68-3.33). MIS approach to rectal cancer surgery was not associated with decreased risk of major LARS and should not be touted as a reason to offer MIS.

Identifiants

pubmed: 39243727
pii: S0748-7983(24)00713-3
doi: 10.1016/j.ejso.2024.108661
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108661

Informations de copyright

Copyright © 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

Richard Garfinkle (R)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.

Katherine A Bews (KA)

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.

William R G Perry (WRG)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.

Kevin T Behm (KT)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.

Robert R Cima (RR)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.

Kellie L Mathis (KL)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.

Nicholas P McKenna (NP)

Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: mckenna.nicholas@mayo.edu.

Classifications MeSH